Delving into the Latest Updates on Delta Crystallon BV with Synapse

A Phase IIa, Randomized, Double-blind, Placebo-controlled, Exploratory, Dose-ranging Study to Evaluate the Safety, Effectiveness and Pharmacokinetics of Three Courses of DC-TAB Treatment in Patients With Multiple Sclerosis

The purpose of this study is to evaluate safety and clinical efficacy of DC-TAB in multiple sclerosis.

开始日期2012-09-01

申办/合作机构

Delta Crystallon BV

NL-OMON34913

/ CompletedN/A

*A Phase I, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and T-cell tolerizing effect of DC-TAB in healthy volunteers, after single and multiple dosing* - A phase I trial with DC-TAB

开始日期2009-12-04

申办/合作机构

Delta Crystallon BV

NCT02442557

/ Completed临床1期

A Phase I, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and T-cell Tolerizing Effect of DC-TAB in Healthy Volunteers

The purpose of this study is to determine safety and appropriate dose of DC-TAB for selective immune tolerance induction in humans.

开始日期2009-12-01

申办/合作机构

Delta Crystallon BV

100 项与 Delta Crystallon BV 相关的临床结果

登录后查看更多信息

0 项与 Delta Crystallon BV 相关的专利（医药）

登录后查看更多信息

100 项与 Delta Crystallon BV 相关的药物交易

登录后查看更多信息

100 项与 Delta Crystallon BV 相关的转化医学

登录后查看更多信息